**7.7 Anti-hepcidin agents**

Lexaptepid pegol and human anti-BMP6 antibodies are hepcidin-suppressing agents. Experimental use of anti-BMP6 antibodies reduced the need for EPO in the treatment of anemia of chronic disease. Other agents targeting the ferroportin degradation action of hepcidin are for underway research [69].
